Michael Minogue President and Chief Executive Officer of Abiomed, Inc. (ABMD), preside over the Market Close

Thursday, December 28, 2006
at NASDAQ's MarketSite
in New York City.

Abiomed, Inc.
[ABMD]

Michael Minogue President and Chief Executive Officer of Abiomed, Inc. (ABMD) will preside over the closing bell.

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. Abiomed currently manufactures and sells the AB5000(tm) Circulatory Support System and the BVS(r) 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts. The Company also developed the AbioCor(r) Implantable Replacement Heart. In Europe, Abiomed offers the minimally invasive Impella(r) Circulatory Support System under CE Mark approval. The Impella(r) 5.0 and 2.5 are investigational devices limited by Federal Law solely to investigational use in the United States. Other Impella devices are not yet available for sale in the United States. For additional information please visit: www.abiomed.com .

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 12/28/2706 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Michael Minogue President and Chief Executive Officer of Abiomed, Inc., signs The NASDAQ Stock Market Closing Bell podium. These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.